insights_auto
为什么 DRUG 上涨了 9.18%?
深入探索chevron_right
DRUG:NASDAQ
Bright Minds Biosciences Inc
US$20.70
arrow_upward
+9.18%(+1.74) 1 天
11月5日, GMT-5 16:00:01 · USD
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 DRUG 生成关键数据洞见…
开盘价
US$18.75
最高价
US$20.86
最低价
US$17.40
市值
2.56亿
平均成交量
23.67万
成交量
43.89万
52 周最高价
US$123.75
52 周最低价
US$17.40
Beta 版
-4.94
流通股数
986.40万
员工人数
26
开盘价
US$18.75
最高价
US$20.86
最低价
US$17.40
市值
2.56亿
平均成交量
23.67万
成交量
43.89万
52 周最高价
US$123.75
52 周最低价
US$17.40
Beta 版
-4.94
流通股数
986.40万
员工人数
26
新闻报道
来自网络来源和新闻合作伙伴
Seeking Alpha
·
18小时前
Bright Minds Biosciences: Promising Catalysts Despite The FDA Setback
Investing.com
·
3天前
Why is Bright Minds Biosciences stock collapsing today?
资料
Bright Minds Biosciences is an American pharmaceutical company which is developing serotonin 5-HT₂ receptor agonists for potential medical use.
It has a particular focus on serotonin 5-HT2C receptor agonists, for instance to treat rare epilepsies and other conditions. Another area of focus for the company is serotonergic psychedelics and non-hallucinogenic psychoplastogens.
The company was co-founded by Ian McDonald and Gideon Shapiro. The lead scientist at Bright Minds Biosciences was previously Alan Kozikowski. Bright Mind Biosciences was founded in 2017 and its headquarters are in New York City, New York. Wikipedia
Bright Minds Biosciences Inc简介